618 related articles for article (PubMed ID: 38367866)
1. Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches.
Williams LM; Cao S
Pharmacol Ther; 2024 Apr; 256():108605. PubMed ID: 38367866
[TBL] [Abstract][Full Text] [Related]
2. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
3. Gut microbial metabolites SCFAs and chronic kidney disease.
He M; Wei W; Zhang Y; Xiang Z; Peng D; Kasimumali A; Rong S
J Transl Med; 2024 Feb; 22(1):172. PubMed ID: 38369469
[TBL] [Abstract][Full Text] [Related]
4. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
Gasaly N; de Vos P; Hermoso MA
Front Immunol; 2021; 12():658354. PubMed ID: 34122415
[TBL] [Abstract][Full Text] [Related]
5. Dietary SCFAs, IL-22, and GFAP: The Three Musketeers in the Gut-Neuro-Immune Network in Type 1 Diabetes.
Jayasimhan A; Mariño E
Front Immunol; 2019; 10():2429. PubMed ID: 31736937
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease.
Russo E; Giudici F; Fiorindi C; Ficari F; Scaringi S; Amedei A
Front Immunol; 2019; 10():2754. PubMed ID: 31824517
[TBL] [Abstract][Full Text] [Related]
7. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.
Parada Venegas D; De la Fuente MK; Landskron G; González MJ; Quera R; Dijkstra G; Harmsen HJM; Faber KN; Hermoso MA
Front Immunol; 2019; 10():277. PubMed ID: 30915065
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.
Lavelle A; Sokol H
Nat Rev Gastroenterol Hepatol; 2020 Apr; 17(4):223-237. PubMed ID: 32076145
[TBL] [Abstract][Full Text] [Related]
9. Medical School Hotline: Immunoepigenetic-Microbiome Axis: Implications for Health Disparities Research in Native Hawaiians and Pacific Islanders.
Rubas NC; Maunakea A
Hawaii J Health Soc Welf; 2021 Aug; 80(8):195-198. PubMed ID: 34355196
[TBL] [Abstract][Full Text] [Related]
10. Dietary Fiber from Oat and Rye Brans Ameliorate Western Diet-Induced Body Weight Gain and Hepatic Inflammation by the Modulation of Short-Chain Fatty Acids, Bile Acids, and Tryptophan Metabolism.
Kundi ZM; Lee JC; Pihlajamäki J; Chan CB; Leung KS; So SSY; Nordlund E; Kolehmainen M; El-Nezami H
Mol Nutr Food Res; 2021 Jan; 65(1):e1900580. PubMed ID: 32526796
[TBL] [Abstract][Full Text] [Related]
11. Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota.
Fusco W; Lorenzo MB; Cintoni M; Porcari S; Rinninella E; Kaitsas F; Lener E; Mele MC; Gasbarrini A; Collado MC; Cammarota G; Ianiro G
Nutrients; 2023 May; 15(9):. PubMed ID: 37432351
[TBL] [Abstract][Full Text] [Related]
12. The nutrition-gut microbiome-physiology axis and allergic diseases.
McKenzie C; Tan J; Macia L; Mackay CR
Immunol Rev; 2017 Jul; 278(1):277-295. PubMed ID: 28658542
[TBL] [Abstract][Full Text] [Related]
13. Short-chain fatty acid - A critical interfering factor for allergic diseases.
Liu Y; Liu J; Du M; Yang H; Shi R; Shi Y; Zhang S; Zhao Y; Lan J
Chem Biol Interact; 2023 Nov; 385():110739. PubMed ID: 37805176
[TBL] [Abstract][Full Text] [Related]
14. Metabolite trajectories across the perinatal period and mental health: A preliminary study of tryptophan-related metabolites, bile acids and microbial composition.
Kimmel M; Jin W; Xia K; Lun K; Azcarate-Peril A; Plantinga A; Wu M; Ataei S; Rackers H; Carroll I; Meltzer-Brody S; Fransson E; Knickmeyer R
Behav Brain Res; 2022 Feb; 418():113635. PubMed ID: 34755640
[TBL] [Abstract][Full Text] [Related]
15. Intracerebroventricular Delivery of Gut-derived Microbial Metabolites in Freely Moving Mice.
Liou CW; Yao TH; Wu WL
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35723471
[TBL] [Abstract][Full Text] [Related]
16. Gut-microbiota derived bioactive metabolites and their functions in host physiology.
Debnath N; Kumar R; Kumar A; Mehta PK; Yadav AK
Biotechnol Genet Eng Rev; 2021 Oct; 37(2):105-153. PubMed ID: 34678130
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO.
Poll BG; Cheema MU; Pluznick JL
Physiology (Bethesda); 2020 Jul; 35(4):275-284. PubMed ID: 32490748
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.
Portincasa P; Bonfrate L; Vacca M; De Angelis M; Farella I; Lanza E; Khalil M; Wang DQ; Sperandio M; Di Ciaula A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163038
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Arterial Hypertension Patients Have a Proinflammatory Gut Microbiome and Altered Circulating Microbial Metabolites.
Moutsoglou DM; Tatah J; Prisco SZ; Prins KW; Staley C; Lopez S; Blake M; Teigen L; Kazmirczak F; Weir EK; Kabage AJ; Guan W; Khoruts A; Thenappan T
Am J Respir Crit Care Med; 2023 Mar; 207(6):740-756. PubMed ID: 36343281
[No Abstract] [Full Text] [Related]
20. Immunomodulatory Effects of Microbiota-Derived Short-Chain Fatty Acids in Autoimmune Liver Diseases.
Zhang W; Mackay CR; Gershwin ME
J Immunol; 2023 Jun; 210(11):1629-1639. PubMed ID: 37186939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
